These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11516874)

  • 1. Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy.
    Xia P; Pickett B; Vigneault E; Verhey LJ; Roach M
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):244-54. PubMed ID: 11516874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy.
    Pickett B; Vigneault E; Kurhanewicz J; Verhey L; Roach M
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):921-9. PubMed ID: 10386651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.
    De Meerleer GO; Vakaet LA; De Gersem WR; De Wagter C; De Naeyer B; De Neve W
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):639-48. PubMed ID: 10837946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.
    van Lin EN; Fütterer JJ; Heijmink SW; van der Vight LP; Hoffmann AL; van Kollenburg P; Huisman HJ; Scheenen TW; Witjes JA; Leer JW; Barentsz JO; Visser AG
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):291-303. PubMed ID: 16618584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT.
    Wang L; Movsas B; Jacob R; Fourkal E; Chen L; Price R; Feigenberg S; Konski A; Pollack A; Ma C
    J Appl Clin Med Phys; 2004; 5(2):29-41. PubMed ID: 15738911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol.
    Mott JH; Livsey JE; Logue JP
    Br J Radiol; 2004 May; 77(917):377-86. PubMed ID: 15121701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy.
    Nutting CM; Corbishley CM; Sanchez-Nieto B; Cosgrove VP; Webb S; Dearnaley DP
    Br J Radiol; 2002 Feb; 75(890):151-61. PubMed ID: 11893639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A feasibility study of automated inverse treatment planning for cancer of the prostate.
    Reinstein LE; Wang XH; Burman CM; Chen Z; Mohan R; Kutcher G; Leibel SA; Fuks Z
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):207-14. PubMed ID: 9422578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing.
    Dogan N; King S; Emami B; Mohideen N; Mirkovic N; Leybovich LB; Sethi A
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1480-91. PubMed ID: 14630288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters.
    Riches SF; Payne GS; Desouza NM; Dearnaley D; Morgan VA; Morgan SC; Partridge M
    Br J Radiol; 2014 May; 87(1037):20130813. PubMed ID: 24601648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
    Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of collimator leaf width on stereotactic radiosurgery and 3D conformal radiotherapy treatment plans.
    Kubo HD; Wilder RB; Pappas CT
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):937-45. PubMed ID: 10386653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparison of radiotherapy techniques for treatment of the prostate cancer: the three-field vs. the four-field.
    Milecki P; Piotrowski T; Dymnicka M
    Neoplasma; 2004; 51(1):64-9. PubMed ID: 15004663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.
    Kuang Y; Wu L; Hirata E; Miyazaki K; Sato M; Kwee SA
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1017-25. PubMed ID: 25832692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland.
    Mohan DS; Kupelian PA; Willoughby TR
    Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):575-80. PubMed ID: 10701736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric advantage and clinical implication of a micro-multileaf collimator in the treatment of prostate with intensity-modulated radiotherapy.
    Wang L; Hoban P; Paskalev K; Yang J; Li J; Chen L; Xiong W; Ma CC
    Med Dosim; 2005; 30(2):97-103. PubMed ID: 15922176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations on treatment efficiency of different conformal radiation therapy techniques for prostate cancer.
    Verellen D; Linthout N; Soete G; Van Acker S; De Roover P; Storme G
    Radiother Oncol; 2002 Apr; 63(1):27-36. PubMed ID: 12065100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
    Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.